Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.42 |
| ▸ | DAO | P14920 | 3/20 | 0.40 |
| ▸ | CA12 | O43570 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | CA7 | P43166 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | ACHE | P22303 | 1/20 | 0.39 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.38 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.38 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.37 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.37 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.37 |
| ▸ | CYP2A13 | Q16696 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5248699 | 0.93 | TAAR1 (0.54) | TAAR1MAPTCHRM2DAOCA12 | |
| SCHEMBL10865658 | 0.91 | TAAR1 (0.52) | TAAR1MAPTCHRM2DAOCA12 | |
| SCHEMBL9650526 | 0.91 | TAAR1 (0.52) | TAAR1MAPTCHRM2DAOCA12 | |
| SCHEMBL7454141 | 0.86 | TAAR1 (0.60) | TAAR1MAPTCHRM2DAOCA12 | |
| SCHEMBL6546881 | 0.85 | TAAR1 (0.65) | TAAR1CHRM2DAOCA12CA1 | |
| SCHEMBL6546757 | 0.85 | TAAR1 (0.65) | TAAR1CHRM2DAOCA12CA1 | |
| SCHEMBL8098051 | 0.83 | TAAR1 (0.62) | TAAR1CHRM2DAOCA12CA1 | |
| SCHEMBL8095309 | 0.83 | TAAR1 (0.62) | TAAR1CHRM2DAOCA12CA1 | |
| SCHEMBL8085424 | 0.83 | TAAR1 (0.62) | TAAR1CHRM2DAOCA12CA1 | |
| SCHEMBL8098360 | 0.83 | TAAR1 (0.62) | TAAR1CHRM2DAOCA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140303333-A1 | IRON BISPHENOLATE COMPLEXES AND METHODS OF USE AND SYNTHESIS THEREOF | UNIV PRINCE EDWARD ISLAND (CA) | 2014-10-09 | — | — | US | disclosed |
| US-20140303333-A1 | IRON BISPHENOLATE COMPLEXES AND METHODS OF USE AND SYNTHESIS THEREOF | UNIV PRINCE EDWARD ISLAND (CA) | 2014-10-09 | — | — | US | disclosed |
| US-4562286-A | Process for preparing methoxytrifluoromethylnaphthoic acid from dimethylnaphthalene | OCCIDENTAL CHEMICAL CORPORATION (US) | 1985-12-31 | — | — | US | disclosed |
| US-4560794-A | Process for preparing methoxytrifluoromethylnaphthoic acid from methylnaphthoic acid | OCCIDENTAL CHEMICAL CORPORATION (US) | 1985-12-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140303333-A1 | IRON BISPHENOLATE COMPLEXES AND METHODS OF USE AND SYNTHESIS THEREOF | TFRC, PCBP1, FECH | TAAR1 696/4885MAPT 2515/4885CHRM2 4281/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.